Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.340
+0.010 (0.75%)
At close: Nov 22, 2024, 4:00 PM
1.330
-0.010 (-0.75%)
After-hours: Nov 22, 2024, 6:24 PM EST
Vivani Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2006 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '06 Dec 31, 2006 |
| Revenue | - | - | - | - | - | 1.81 | |
| Revenue Growth (YoY) | - | - | - | - | - | -21.06% | |
| Selling, General & Admin | 8.28 | 10 | 5.37 | 2.32 | 2.38 | - | |
| Research & Development | 16.15 | 16.97 | 14.17 | 11 | 6.87 | - | |
| Operating Expenses | 24.43 | 26.97 | 19.54 | 13.32 | 9.24 | - | |
| Operating Income | -24.43 | -26.97 | -19.54 | -13.32 | -9.24 | - | |
| Interest & Investment Income | 1.5 | 1.5 | - | - | - | - | |
| Other Non Operating Income (Expenses) | -0.53 | -0.19 | 0.48 | 0.55 | -0.04 | - | |
| EBT Excluding Unusual Items | -23.46 | -25.65 | -19.07 | -12.77 | -9.28 | - | |
| Legal Settlements | - | - | -1.7 | - | - | - | |
| Other Unusual Items | - | - | 6.88 | - | - | - | |
| Pretax Income | -23.46 | -25.65 | -13.89 | -12.77 | -9.28 | - | |
| Earnings From Continuing Operations | - | -25.65 | -13.89 | -12.77 | -9.28 | - | |
| Net Income | -23.46 | -25.65 | -13.89 | -12.77 | -9.28 | -7.21 | |
| Net Income to Common | -23.46 | -25.65 | -13.89 | -12.77 | -9.28 | - | |
| Shares Outstanding (Basic) | 53 | 51 | 38 | 33 | 10 | - | |
| Shares Outstanding (Diluted) | 53 | 51 | 38 | 33 | 10 | - | |
| Shares Change (YoY) | 11.21% | 32.98% | 15.56% | 234.38% | - | - | |
| EPS (Basic) | -0.44 | -0.50 | -0.36 | -0.39 | -0.94 | - | |
| EPS (Diluted) | -0.44 | -0.50 | -0.36 | -0.39 | -0.94 | - | |
| Free Cash Flow | -19.46 | -24.59 | -19.13 | -11.52 | -7.77 | - | |
| Free Cash Flow Per Share | -0.36 | -0.48 | -0.50 | -0.35 | -0.79 | - | |
| EBITDA | -24.03 | -26.61 | -19.16 | -12.98 | -8.89 | - | |
| D&A For EBITDA | 0.41 | 0.36 | 0.38 | 0.35 | 0.35 | - | |
| EBIT | -24.43 | -26.97 | -19.54 | -13.32 | -9.24 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.